Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Neoadjuvant dose-dense gemcitabine and cisplatin (DDGC) in patients (pts) with muscle-invasive bladder cancer (MIBC): Final results of a multicenter phase II study

Plimack ER, Hoffman-Censits JH, Kutikov A, Greenberg RE, Bilusic M, Chen DYT, Viterbo R, Lallas CD, Lin J, Trabulsi EJ, Geynisman DM, Kelly WK, Smaldone MC, Devarajan K, Adaire-Halenda B, Cione C, Kilpatrick D, Duncan G, Wong YN.

Journal of Clinical Oncology (2014) 32:5 (Suppl; Abstract 4513)